AZ13705339 hemihydrate

• CAT Number: I042850
• Molecular Formula: C33H36FN7O3S.1/2H2O
• Molecular Weight: 638.77
• Purity: ≥95%
• IUPAC Name: 2-[[N-[2-[3-ethylsulfonyl-4-(4-methylpiperazin-1-yl)anilino]-5-fluoropyrimidin-4-yl]-5-(hydroxymethyl)-2-methylanilino]methyl]benzonitrile;hydrate
• InChI: InChI=1S/C33H36FN7O3S.H2O/c1-4-45(43,44)31-18-27(11-12-29(31)40-15-13-39(3)14-16-40)37-33-36-20-28(34)32(38-33)41(21-26-8-6-5-7-25(26)19-35)30-17-24(22-42)10-9-23(30)2;/h5-12,17-18,20,42H,4,13-16,21-22H2,1-3H3,(H,36,37,38);1H2
• InChIKey: LKWDIBDWPNRHBM-UHFFFAOYSA-N
• SMILES: CCS(=O)(=O)C1=C(C=CC(=C1)NC2=NC=C(C(=N2)N(CC3=CC=CC=C3C#N)C4=C(C=CC(=C4)CO)C)F)N5CCN(CC5)C.O

AZ13705339 hemihydrate（Cat No.:I042850）is an experimental compound under investigation for its potential in treating various diseases, including cancer and inflammatory conditions. It is a selective inhibitor of specific kinases involved in cell signaling pathways that regulate cell growth, survival, and immune responses. By targeting these pathways, AZ13705339 hemihydrate aims to block tumor progression and enhance immune system activity. Preclinical studies suggest it may be effective against certain types of cancer and autoimmune diseases. Ongoing research is focused on assessing its safety, efficacy, and therapeutic potential in clinical trials.